Code Life Research Awards Ceremony
Researchers at the RI-MUHC receive support from the Montreal General Hospital Foundation and the Cedars Cancer Foundation
Last night, the Code Life Research Awards ceremony celebrated the researchers of the Research Institute of the McGill University Health Centre (RI-MUHC), supporting their innovative projects with millions of dollars from the Montreal General Hospital Foundation. This year, the Cedars Cancer Foundation joined the program to offer new awards in oncology. In total, 60 researchers received 90 grants, representing annual funding of $1.6 million.
The ceremony was also an opportunity to pay tribute to Dr. Phil Gold, whose discovery in 1965 of the first cancer marker, the carcinoembryonic antigen (CEA), set a major turning point in oncology and inspired generations of researchers.
To mark this tribute, the Research Institute Pavilion at the Montreal General Hospital will soon bear his name.
“It is an honour to recognize and reward the incredible work of our scientists and investigators, who are advancing so many aspects of health research,” said Dr. Rhian Touyz, Executive Director and Chief Scientific Officer of the RI-MUHC. “We thank the Foundations and their generous donors, who are undoubtedly playing a role in advancing research.”
“The Dr. Phil Gold Pavilion accommodates many of our researchers in the Centre for Outcomes Research and Evaluation, as well as those involved with clinical trials and translational research. It will also house new research programs in surgery robotics,” added Dr. Touyz. “I am delighted that this building is being named in honour of Dr. Gold, as a tribute to the years he has spent dedicating his life to scientific research, and to improving the health of Canadians.”
Discover the list of recipients.